Jürg Reichen

6.7k citations
139 papers · 5.3k indexed · 1 hit paper · h-index 37

Impact in

  • Hepatology top 0.2%
    • Liver Disease and Transplantation
    • Hepatitis C virus research
  • Epidemiology top 0.5%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Liver Disease and Transplantation 50
    • Hepatitis C virus research 15
    • Drug-Induced Hepatotoxicity and Protection 14
    • Pharmacogenetics and Drug Metabolism 11

Jürg Reichen

139 papers receiving 5.1k citations

Hit Papers

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C 2000 · 954 citations
9542000202620082017250500750

Peers

Jürg Reichen
Comparison fields: 5 of 125
  • Hepatology 2.8k
  • Epidemiology 2.6k
  • Pharmacology 541
  • Clinical Biochemistry 322
  • Oncology 1.0k
Replace M. J. Phillips with:
M. J. Phillips Canada
Gary C. Kanel United States
Élie Serge Zafrani France
Hideyuki Miyoshi Japan
Makoto Nakamuta Japan
Chantal Housset France
Andrew D. Clouston Australia
Geum‐Youn Gwak South Korea
Graeme Alexander United Kingdom
M. Angélico Italy
Jürg Reichen relative to M. J. Phillips Canada M. J. Phillips's profile →
Citations per field
00.5×1.5×2.1×
M. J. Phillips · 1×
Citations per year

Countries citing papers authored by Jürg Reichen

Since Specialization
Citations

This map shows the geographic impact of Jürg Reichen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürg Reichen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürg Reichen more than expected).

Fields of papers citing papers by Jürg Reichen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürg Reichen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürg Reichen. The network helps show where Jürg Reichen may publish in the future.

Co-authors

The 25 scholars most cited alongside Jürg Reichen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jürg Reichen Line = papers co-authored together Jürg Reichen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 200727
2 200711
3 200320
4 200263
5 200114
6 200127
7 200016
8 200072
9 19998
10 199914
11 199615
12 199429
13 199326
14 199241
15 199094
16 199062
17 19893
18 198889
19 198820
20 198719

About Jürg Reichen

Jürg Reichen is a scholar working on Hepatology, Pharmacology, Clinical Biochemistry, Epidemiology and Biochemistry, having authored 139 papers that have together received 5.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (62 papers), Liver Disease and Transplantation (50 papers), Drug Transport and Resistance Mechanisms (31 papers), Hepatitis C virus research (15 papers), Metabolism and Genetic Disorders (14 papers), Drug-Induced Hepatotoxicity and Protection (14 papers), Eicosanoids and Hypertension Pharmacology (11 papers) and Pharmacogenetics and Drug Metabolism (11 papers). The work is most often cited by research in Hepatology (2.8k citations), Epidemiology (2.6k citations), Pharmacology (541 citations), Clinical Biochemistry (322 citations) and Oncology (1.0k citations). Jürg Reichen has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include G. Paumgartner, Stephan Krähenbühl, S.V. Feinman, Edward Gane, Michael J. Brunda, J. Rasenack, John O’Grady, E. Jenny Heathcote, M. Diago and Amy Lin. Their work appears in journals such as Journal of Hepatology, Hepatology, Cellular and Molecular Life Sciences, Gastroenterology and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026